TradingMarkets’ 13 Stocks You Need To Know About Today

Freddie Mac
(
FRE |
Quote |
Chart |
News |
PowerRating) posted 2004 net income that was off 40%.

Biogen Idec
(
BIIB |
Quote |
Chart |
News |
PowerRating) and Elan
(
ELN |
Quote |
Chart |
News |
PowerRating) will be in focus
after a third patient contracted an often fatal infection linked to the MS drug,
Tysabri. Two patients have died from this previously. Both stocks are trading
lower pre-open.

Ruby Tuesday
(
RI |
Quote |
Chart |
News |
PowerRating) cut its Q4 earnings forecast.

Western Digital
(
WDC |
Quote |
Chart |
News |
PowerRating) raised its Q3 targets; the stock is trading
higher pre-open as are competitors Seagate
(
STX |
Quote |
Chart |
News |
PowerRating) and Maxtor
(
MXO |
Quote |
Chart |
News |
PowerRating).

The FDA said that Forest Labs’
(
FRX |
Quote |
Chart |
News |
PowerRating) Lexapro was not approvable
for social anxiety disorder.

Johnson & Johnson
(
JNJ |
Quote |
Chart |
News |
PowerRating), Biomet
(
BMET |
Quote |
Chart |
News |
PowerRating) and Stryker
(
SYK |
Quote |
Chart |
News |
PowerRating) will be in focus as the Justice Department begins an investigation of
orthopdedic companies

S&P cut American International Group’s
(
AIG |
Quote |
Chart |
News |
PowerRating) debt ratings to AA+
from AAA and said they may cut them again, saying accounting errors raise
questions about the management’s integrity. Bank of America reiterated its ‘buy’
rating.

Yum Brands
(
YUM |
Quote |
Chart |
News |
PowerRating) downgraded at CSFB, to neutral.